Skip to main content
Fig. 4 | Trials

Fig. 4

From: Community-led Responses for Elimination (CoRE): a study protocol for a community randomized controlled trial assessing the effectiveness of community-level, reactive focal drug administration for reducing Plasmodium falciparum infection prevalence and incidence in Southern Province, Zambia

Fig. 4

Participant flow chart to determine antimalarial treatment regimen under reactive focal mass drug administration (RFDA) with DHAP. WRA (15–49 years) women of reproductive age 15 to 49 years old; mRDT malaria rapid diagnostic test, HC health center, AL artemether-lumefantrine, DHAP dihydroartemethesin-piperaquine. *Individual will be offered standard of care (see Fig. 3)

Back to article page